THE LATEST WORD
Top Industry Stories – January 29, 2010
Posted on January 29th, 2010 | by Rxmedyn | No Comments »Posted in Industry Stories
Top Industry Stories – January 28, 2010
Posted on January 28th, 2010 | by Rxmedyn | No Comments »- AZ Posts 23% Rise in 2009 Core Profit (PharmaTimes)
- P&G’s Product and Stock Prices Take Stage (The Wall Street Journal)
- Merck Granted European Approval for New Fertility Treatment ELONVA (TradingMarkets)
- EMA Calls for Opinions on its Road Map 2015 (PharmaTimes)
Posted in Industry Stories
Top Industry Stories – January 26, 2010
Posted on January 26th, 2010 | by Rxmedyn | No Comments »Posted in Industry Stories
Top Industry Stories – January 25, 2010
Posted on January 25th, 2010 | by Rxmedyn | No Comments »- China Agrees to Open Up Market for Indian Drugmakers (PharmaTimes)
- A Fibromyalgia Drug That Improves Sleep Quality More Than Pfizer’s Lyrica Would Earn Sizeable Patient Share in the U.S. and Europe (PR Newswire)
- Alcon Investor Expects Novartis to Raise Offer (Reuters)
- EMA’s First “compassionate use” Opinion is for Tamiflu (PharmaTimes)
Posted in Industry Stories
Top Industry Stories – January 22, 201
Posted on January 22nd, 2010 | by Rxmedyn | No Comments »- Abbott Suspends Diet Drug Sales After EMEA Request (PharmaTimes)
- Big Pharma Faces Tougher 2010 Despite US Boost (Reuters)
- SkyePharma Suffers as FDA Turns Down Flutiform NDA (PharmaTimes)
- Novartis Receives Japanese Approval For Three New Medicines (New Statesmen)
Posted in Industry Stories
Top Industry Stories- January 21, 2010
Posted on January 21st, 2010 | by Rxmedyn | No Comments »- Novartis Sneaks Ahead in Race to Deliver MS Pills (PharmaTimes)
- GSK Gives Price Pledge on Experimental Malaria Vaccine (Financial Times)
- Merck HIV Drug from Schering Merger Fails Trials (Reuters)
- Pharma Cuts in Early In-House R&D is Clever Move – Analysts (PharmaTimes)
Posted in Industry Stories
Top Industry Stories- January 19, 2010
Posted on January 19th, 2010 | by Rxmedyn | No Comments »- Incoming EU Health Chief Pledges Action on Patient Drug Info (PharmaTimes)
- FDA Warning on Fake Versions of GSK’s Weight Loss Drug (PharmaTimes)
- J&J Recalls More Products for Contamination (Securing Pharma)
- FDA Extends Review Period for Tarceva Application for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer (PharmaLive)
Posted in Industry Stories
Top Industry Stories -January 15, 2010
Posted on January 15th, 2010 | by Rxmedyn | No Comments »- COPD Drug Spiriva Gets FDA All-Clear (PharmaTimes)
- P&G and PFSweb to Launch E-Commerce Learning Lab (PR Newswire)
- Pharma Firms Help Haiti After Earthquake Horror (PharmaTimes)
- FDA Can’t Regulate Electronic Cigarettes (The New York Times)
Posted in Industry Stories
Top Industry Stories- January 14, 2010
Posted on January 14th, 2010 | by Rxmedyn | No Comments »- US FTC urges Congress to ban “pay-for-delay” deals (PharmaTimes)
- FDA panel backs Recordati’s NAGS deficiency drug (PharmaTimes)
- Swine Flu: False Pandemic? Questions In Europe (Medical News Today)
- Amgen Cancer Push on Bone Drug May Key Stock Turnaround in 2010 (Bloomberg)
Posted in Industry Stories
Top Industry Stories- January 13, 2010
Posted on January 13th, 2010 | by Rxmedyn | No Comments »- EU Demands Details of Pharma “Pay For Delay” Deals (PharmaTimes)
- European Governments Cancel Vaccine Orders (The Wall Street Journal)
- Glaxo Sees Little Generic Threat to Advair (Reuters)
- FDA Draws Back the Veil (FiercePharma Manufacturing)
Posted in Industry Stories
-
Recent Posts
Archives
Careers | © 2009 Medical Dynamics